Scott D. Mosser

3.6k total citations
39 papers, 2.0k citations indexed

About

Scott D. Mosser is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Scott D. Mosser has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 15 papers in Psychiatry and Mental health. Recurrent topics in Scott D. Mosser's work include Migraine and Headache Studies (15 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Neuropeptides and Animal Physiology (11 papers). Scott D. Mosser is often cited by papers focused on Migraine and Headache Studies (15 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Neuropeptides and Animal Physiology (11 papers). Scott D. Mosser collaborates with scholars based in United States, Poland and Italy. Scott D. Mosser's co-authors include W. Wayt Gibbs, Samuel Graham, Allen Oliff, Nancy E. Kohl, Elizabeth A. Giuliani, S. J. DESOLMS, David L. Pompliano, Elaine Rands, Michael D. Schaber and Robert L. Smith and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Scott D. Mosser

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott D. Mosser United States	23	1.3k	611	382	339	296	39	2.0k
Flora Tang United States	17	1.5k 1.2×	518 0.8×	596 1.6×	137 0.4×	562 1.9×	24	2.7k
Qi-Huang Zheng United States	26	681 0.5×	367 0.6×	354 0.9×	130 0.4×	327 1.1×	93	1.9k
Tjeerd Barf Netherlands	19	724 0.6×	229 0.4×	360 0.9×	55 0.2×	267 0.9×	33	1.7k
Jen‐Shin Song Taiwan	22	625 0.5×	273 0.4×	346 0.9×	89 0.3×	132 0.4×	58	1.4k
Yichin Liu United States	21	1.3k 1.0×	404 0.7×	145 0.4×	83 0.2×	259 0.9×	33	2.3k
Lenka Munoz Australia	20	1.0k 0.8×	369 0.6×	184 0.5×	41 0.1×	165 0.6×	38	2.0k
Steven J. McClue United Kingdom	18	731 0.6×	433 0.7×	75 0.2×	70 0.2×	295 1.0×	25	1.2k
Mark E. Duggan United States	26	1.6k 1.2×	271 0.4×	741 1.9×	45 0.1×	713 2.4×	46	2.6k
Mingzhang Gao United States	22	564 0.4×	263 0.4×	494 1.3×	83 0.2×	183 0.6×	89	1.6k
Robert L. Hudkins United States	24	1.3k 1.0×	364 0.6×	650 1.7×	24 0.1×	309 1.0×	89	2.2k

Countries citing papers authored by Scott D. Mosser

Since Specialization

Citations

This map shows the geographic impact of Scott D. Mosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Mosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Mosser more than expected).

Fields of papers citing papers by Scott D. Mosser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Mosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Mosser. The network helps show where Scott D. Mosser may publish in the future.

Co-authorship network of co-authors of Scott D. Mosser

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Mosser. A scholar is included among the top collaborators of Scott D. Mosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Mosser. Scott D. Mosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, Ian M., Craig A. Stump, Steven N. Gallicchio, et al.. (2012). MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorganic & Medicinal Chemistry Letters. 22(12). 3941–3945. 19 indexed citations

Burgey, Christopher S., James Z. Deng, Scott D. Mosser, et al.. (2009). Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines. Bioorganic & Medicinal Chemistry Letters. 19(22). 6368–6372. 11 indexed citations

McIntyre, Charles, John A. McCauley, Bohumil Bednář, et al.. (2009). Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5132–5135. 6 indexed citations

Bell, Ian M., Rodney A. Bednar, John F. Fay, et al.. (2009). The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4740–4742. 5 indexed citations

Wood, Michael R., Craig A. Stump, Ian M. Bell, et al.. (2009). Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorganic & Medicinal Chemistry Letters. 19(19). 5787–5790. 10 indexed citations

Theberge, Cory R., Rodney A. Bednar, Ian M. Bell, et al.. (2008). Potent benzimidazolone-based CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(23). 6122–6125. 8 indexed citations

Paone, Daniel V., Anthony W. Shaw, Diem N. Nguyen, et al.. (2007). Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of N -[(3 R ,6 S )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 H -imidazo[4,5- b ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974). Journal of Medicinal Chemistry. 50(23). 5564–5567. 114 indexed citations

Nguyen, Kevin T., Christopher F. Claiborne, John A. McCauley, et al.. (2007). Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3997–4000. 19 indexed citations

Salvatore, Christopher, James C. Hershey, John F. Fay, et al.. (2007). Pharmacological Characterization of MK-0974 [N-[(3 R,6 S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1 H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine. Journal of Pharmacology and Experimental Therapeutics. 324(2). 416–421. 115 indexed citations

10.

Williams, Theresa M., Craig A. Stump, Diem N. Nguyen, et al.. (2006). Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead. Bioorganic & Medicinal Chemistry Letters. 16(10). 2595–2598. 39 indexed citations

11.

Dinsmore, Christopher J., C. Blair Zartman, Jeffrey M. Bergman, et al.. (2004). Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 14(3). 639–643. 8 indexed citations

12.

Hershey, James C., Elizabeth Baskin, Christopher Salvatore, et al.. (2004). Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay. Regulatory Peptides. 127(1-3). 71–77. 45 indexed citations

13.

Buser, Carolyn A., Christopher J. Dinsmore, Christine Fernandes, et al.. (2001). High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123. Analytical Biochemistry. 290(1). 126–137. 24 indexed citations

14.

Subler, Mark A., Elaine Rands, Charles A. Omer, et al.. (1998). A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis. Molecular and Cellular Biology. 18(1). 85–92. 147 indexed citations

15.

Breslin, Michael J., S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1998). Potent, non-thiol inhibitors of farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 8(23). 3311–3316. 22 indexed citations

16.

Wallace, Andrew, Kenneth S. Koblan, Kelly Hamilton, et al.. (1996). Selection of Potent Inhibitors of Farnesyl-protein Transferase from a Synthetic Tetrapeptide Combinatorial Library. Journal of Biological Chemistry. 271(49). 31306–31311. 42 indexed citations

17.

Kohl, Nancy E., et al.. (1995). [38] Inhibition of Ras function in Vitro and in Vivo using inhibitors of farnesyl-protein transferase. Methods in enzymology on CD-ROM/Methods in enzymology. 255. 378–386. 9 indexed citations

18.

Wai, John, Thorsten E. Fisher, Samuel Graham, et al.. (1994). Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages. Bioorganic & Medicinal Chemistry. 2(9). 939–947. 23 indexed citations

19.

Graham, Samuel, S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1994). Pseudopeptide Inhibitors of Ras Farnesyl-Protein Transferase. Journal of Medicinal Chemistry. 37(6). 725–732. 88 indexed citations

20.

Marshall, Mark S., Lenora J. Davis, Robert D. Keys, et al.. (1991). Identification of Amino Acid Residues Required for Ras p21 Target Activation. Molecular and Cellular Biology. 11(8). 3997–4004. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact